MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:197107 chebi:197107 ZGBAJMQHJDFTQJ-DEOSSOPVSA-N | Bafetinib 4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(triluoromethyl)benzamide |
kegg.drug:D10202 keggD:D10202 ZGBAJMQHJDFTQJ-DEOSSOPVSA-N | Bafetinib (USAN) |
| hmdb:HMDB0240206 ZGBAJMQHJDFTQJ-DEOSSOPVSA-N | Bafetinib INNO-406 N-(3-((4,5'-Bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3S)-3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide N-(3-{[4,5'-bipyrimidine]-2-ylamino}-4-methylphenyl)-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide N-[3-({[4,5'-bipyrimidine]-2-yl}amino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide NS-187inno-406BAFETINIB |
keggD:M_D10202 | secondary/obsolete/fantasy identifier |